Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313487582> ?p ?o ?g. }
- W4313487582 abstract "Abstract Human decisions are frequently explained as the balancing of potential rewards and punishments, such as food, money, or lost time. However, rational models of decision making based on this idea often fail to accurately predict human behavior. Humans and other animals appear to base decisions on value estimation that is often not clearly linked to extrinsic outcomes. For example, humans prefer to choose, even when doing so has no clear impact on impending rewards or punishments. Thus, choice opportunities may be intrinsically rewarding. There is limited evidence about the mechanisms underlying intrinsic rewards, and it is unclear how deficits in motivation for intrinsic rewards manifest themselves following impairment of brain networks involved in reward processing such as the dopaminergic and cortico-basal ganglia systems. Here we seek to understand how extrinsic and intrinsic rewards act together to guide decisions. We designed a decision-making task that separates the intrinsic value of free choice from the value of extrinsic rewards received for correct performance. We investigated the neural mechanisms underlying choice preference by asking Parkinson’s disease patients to perform the task ON and OFF treatment. We tested two groups of patients to explore the effects of dopamine medication and potential modulation of wider cortical areas by deep brain stimulation. One group was treated with acute dopamine replacement therapy, and another group was treated with subthalamic nucleus deep brain stimulation. On average, patients ON dopaminergic treatment preferred to choose even when they risked losing extrinsic rewards ( z =3.736, P =0.004). However, we found a significant interaction with the level of chronic levodopa therapy ( z =2.643, P =0.008); patients with low doses of levodopa treatment in their daily lives did not prefer to choose ( z =0.901, P =0.60), nor was this indifference modulated by acute levodopa administration ( z =0.227, P =0.996). Deep brain stimulation patients were similarly indifferent to choice opportunities when OFF stimulation ( z =-0.95, P =0.339). Like patients with low chronic levodopa treatment in the first group, all deep brain stimulation patients received low-dosage chronic levodopa treatment, which is one of the principal effects of this surgical intervention. Interestingly, in deep brain stimulation patients, choice preference could be re-established by subthalamic nucleus stimulation ( z =3.07, P =0.011). This was associated with increased structural connectivity between subthalamic nucleus stimulation sites and the medial frontal cortex (including Brodmann areas 8, 9, and 32; P <0.05 corrected for multiple comparisons). In contrast to healthy humans who typically prefer choice, patients with the most severe dopamine depletion (advanced disease together with low chronic dopamine replacement therapy) did not prefer to choose. Our results suggests that higher levels of chronic dopamine medication or deep brain stimulation can increase motivation to seek choice opportunities. This is likely due to different mechanisms, with dopamine medication affecting sensitivity to all rewards and deep brain stimulation affecting impulsivity. These results advance our understanding of intrinsic reward and its interplay with general motivational processes associated with behavioral impairments observed in Parkinson’s disease and other neuropsychiatric disorders involving the dopaminergic system." @default.
- W4313487582 created "2023-01-06" @default.
- W4313487582 creator A5011117537 @default.
- W4313487582 creator A5042358690 @default.
- W4313487582 creator A5044329318 @default.
- W4313487582 creator A5045353188 @default.
- W4313487582 creator A5048881016 @default.
- W4313487582 creator A5056460028 @default.
- W4313487582 creator A5074012261 @default.
- W4313487582 date "2023-01-04" @default.
- W4313487582 modified "2023-10-18" @default.
- W4313487582 title "Deep brain stimulation and dopamine medication enhance free choice preference in Parkinson’s disease" @default.
- W4313487582 cites W1501501601 @default.
- W4313487582 cites W1533056363 @default.
- W4313487582 cites W1562208008 @default.
- W4313487582 cites W1815043210 @default.
- W4313487582 cites W1970928383 @default.
- W4313487582 cites W1974898145 @default.
- W4313487582 cites W1978122571 @default.
- W4313487582 cites W1983297775 @default.
- W4313487582 cites W1987132041 @default.
- W4313487582 cites W1991216670 @default.
- W4313487582 cites W1998727513 @default.
- W4313487582 cites W1999608458 @default.
- W4313487582 cites W2008560062 @default.
- W4313487582 cites W2008565771 @default.
- W4313487582 cites W2009467270 @default.
- W4313487582 cites W2010073791 @default.
- W4313487582 cites W2015447804 @default.
- W4313487582 cites W2015770890 @default.
- W4313487582 cites W2020522596 @default.
- W4313487582 cites W2020745232 @default.
- W4313487582 cites W2021262875 @default.
- W4313487582 cites W2022987442 @default.
- W4313487582 cites W2024609822 @default.
- W4313487582 cites W2029096622 @default.
- W4313487582 cites W2032498657 @default.
- W4313487582 cites W2033621157 @default.
- W4313487582 cites W2034640913 @default.
- W4313487582 cites W2045110140 @default.
- W4313487582 cites W2046557060 @default.
- W4313487582 cites W2047471489 @default.
- W4313487582 cites W2052729098 @default.
- W4313487582 cites W2063764383 @default.
- W4313487582 cites W2072170505 @default.
- W4313487582 cites W2075670547 @default.
- W4313487582 cites W2076183352 @default.
- W4313487582 cites W2080177176 @default.
- W4313487582 cites W2087909380 @default.
- W4313487582 cites W2088135512 @default.
- W4313487582 cites W2092462980 @default.
- W4313487582 cites W2096435819 @default.
- W4313487582 cites W2098354188 @default.
- W4313487582 cites W2098445519 @default.
- W4313487582 cites W2104183285 @default.
- W4313487582 cites W2104523108 @default.
- W4313487582 cites W2104822204 @default.
- W4313487582 cites W2109059823 @default.
- W4313487582 cites W2110166714 @default.
- W4313487582 cites W2115622614 @default.
- W4313487582 cites W2116450435 @default.
- W4313487582 cites W2117726420 @default.
- W4313487582 cites W2118502552 @default.
- W4313487582 cites W2122577131 @default.
- W4313487582 cites W2126449078 @default.
- W4313487582 cites W2133641319 @default.
- W4313487582 cites W2135441216 @default.
- W4313487582 cites W2143199409 @default.
- W4313487582 cites W2144534164 @default.
- W4313487582 cites W2147877980 @default.
- W4313487582 cites W2155988679 @default.
- W4313487582 cites W2156743548 @default.
- W4313487582 cites W2156952192 @default.
- W4313487582 cites W2163647009 @default.
- W4313487582 cites W2164733053 @default.
- W4313487582 cites W2167125619 @default.
- W4313487582 cites W2284739415 @default.
- W4313487582 cites W2340133307 @default.
- W4313487582 cites W2343404327 @default.
- W4313487582 cites W2525718045 @default.
- W4313487582 cites W2537018563 @default.
- W4313487582 cites W2559981943 @default.
- W4313487582 cites W2580721287 @default.
- W4313487582 cites W2583340629 @default.
- W4313487582 cites W2588008972 @default.
- W4313487582 cites W2618863395 @default.
- W4313487582 cites W2622109244 @default.
- W4313487582 cites W2763229272 @default.
- W4313487582 cites W2783564415 @default.
- W4313487582 cites W2808883353 @default.
- W4313487582 cites W2912934247 @default.
- W4313487582 cites W2913766627 @default.
- W4313487582 cites W2921354076 @default.
- W4313487582 cites W2950023299 @default.
- W4313487582 cites W2970898057 @default.
- W4313487582 cites W2982668187 @default.
- W4313487582 cites W2995083992 @default.
- W4313487582 cites W2999145246 @default.
- W4313487582 cites W3041344301 @default.
- W4313487582 cites W3047849058 @default.